Undertreatment of PAD: Preventive Management and Treatment Strategies

Description

This activity is part of the Peripheral Artery Disease: Optimizing Treatment Strategies grant.

Target Audience:

This activity is intended for cardiovascular physicians, registered nurses, and pharmacists.   

Important Dates:
Date of Release: January 19, 2022
Term of Approval/Date of Expiration: September 1, 2024

Learner Objectives:
Upon completion of this activity, you should be able to:

Develop a peripheral artery disease (PAD) treatment plan including guideline-directed medical therapy (GDMT) as well as emerging therapeutics.

Acknowledgements:
Supported by an educational grant from: Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC

Faculty:

Philip Goodney, MD, MS

Peer Reviewers:
Aaron W. Aday, MD
Marc P. Bonaca, MD, FACC
Mark Goldberger, MD, FACC

Summary


Availability:	On-Demand
	Expires on Dec 01, 2024


Cost:	FREE


Credit Offered:	No Credit Offered